BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility | News Direct

BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility

BioHarvest Sciences Inc
News release by BioHarvest Sciences Inc

facebook icon linkedin icon twitter icon pinterest icon email icon Vancouver, Canada | April 18, 2024 09:43 AM Eastern Daylight Time

 

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to to unveil two significant agreements that mark a transformative milestone for the company: an equipment purchase agreement for 12 state-of-the-art GMP clean rooms and a long-term lease agreement for a new 80,000 square foot facility in Yavne, Israel.

Sobel elaborated on the exciting developments, highlighting that the new facility represents a major expansion for BioHarvest Sciences. Equipped with industry-leading clean rooms, as well as fully built-out laboratory space and offices, the facility is poised to support the company's ambitious growth plans. Notably, it also provides the necessary infrastructure to accommodate the anticipated expansion of the Contract Development and Manufacturing Organization (CDMO) Business Unit.

The strategic significance of this transaction lies in its immediate access to cutting-edge clean rooms and laboratories, essential for meeting the evolving needs of both the Products Business Unit and CDMO customers. Furthermore, the facility boasts ample additional space, enabling the construction of a new 50-ton manufacturing facility slated for operation in the second half of 2025.

This facility will incorporate upgraded equipment and technologies, representing the second generation of the Botanical Synthesis manufacturing process. These enhancements are designed to optimize production yields and efficiencies, further solidifying BioHarvest Sciences' position as a leader in botanical synthesis technology.

Sobel emphasized that the relocation of Research & Development and corporate administrative offices to the new BioHarvest Campus is imminent, expected to be completed within the next 6-9 months. This consolidation of operations underscores BioHarvest Sciences' commitment to streamlining its operations and fostering collaboration across its various business units.

As BioHarvest Sciences embarks on this exciting new chapter of growth and expansion, Sobel expressed confidence in the company's ability to capitalize on the vast opportunities that lie ahead. With its state-of-the-art facilities and cutting-edge technologies, BioHarvest Sciences is poised to drive innovation and deliver value to its customers and stakeholders alike. Stay tuned for further updates as the company continues to forge ahead on its journey of growth and success.

 

Contact Details

 

Proactive North America

 

+1 604-688-8158

 

NA-editorial@proactiveinvestors.com

project media

Tags

BiotechAgricultureBio-CellFood SupplyTherapeuticsWellnessnutraceutical